POLY RIBOSE SYNTHETASE & ENDOTHELIAL DYSFUNCTION IN IDDM
POLY RIBOSE SYNTHETASE & ENDOTHELIAL DYSFUNCTION IN IDDM
批准号:
6185189
负责人:
CSABA SZABO
金额:
$10.43万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2001-08-31
关键词:
ADP ribosylation DNA damage DNA repair adenine phosphoribosyltransferase apoptosis cellular pathology cellular respiration cytoprotection cytotoxicity diabetic angiopathy enzyme activity enzyme inhibitors flow cytometry genetically modified animals hyperglycemia inflammation insulin dependent diabetes mellitus laboratory mouse oxidative stress pathologic process peroxynitrites tissue /cell culture vascular endothelium
中文摘要
描述(改编自申请人的摘要):多种细胞类型
(包括血管内皮细胞和血管平滑肌细胞),
暴露于细胞毒性氧化剂,如过氧亚硝酸盐,导致细胞
精力旺盛的失败。在DNA链断裂时,核酶聚(ADP)
核糖合成酶(PARS)启动一种耗能、低效的修复
循环,将NAD的ADP核糖基部分转移到蛋白质受体。这个
由此产生的二核苷酸池的耗尽与细胞的过程有关
死亡。在动物和细胞培养模型中,PARs的保护作用
PARS基因的抑制或缺失已被证实。因此,调查人员
建议明确PARs在内皮细胞发育过程中的作用
糖尿病相关高血糖体外模型的损伤。两个具体的
提出的目标是:(1)确定抑制或基因失活
PARS对高脂诱导的血管内皮细胞功能障碍的影响
(2)探讨高血糖的发生机制。
葡萄糖诱导内皮细胞死亡及PARS在此过程中的作用。
英文摘要
DESCRIPTION (adapted from the applicant's abstract): In a variety of cell types
(including vascular endothelial cells and vascular smooth muscle cells),
exposure to cytotoxic oxidants such as peroxynitrite, results in cellular
energetic failure. Upon DNA strand breakage, the nuclear enzyme poly (ADP)
ribose synthetase (PARS) initiates an energy consuming, inefficient repair
cycle, with transfer of the ADP ribosyl moiety of NAD to protein acceptors. The
resultant depletion of dinucleotide pools is implicated in the process of cell
death. In animal and cell culture models, a protective effect of PARS
inhibition or lack of PARS gene has been demonstrated. Thus, the investigators
propose to define the role of PARS in the process of development of endothelial
injury in an in vitro model of diabetes-associated hyperglycemia. Two specific
aims are proposed: (1) to establish whether inhibition or genetic inactivation
of PARS affects the development of endothelial dysfunction induced by high
glucose conditions; and (2) to investigate the mechanism of high
glucose-induced endothelial cell death and the role of PARS in the process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aminooxyacetic Acid Prodrugs for Colon Cancer Therapy
-
批准号:9251701
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2017
-
负责人:CSABA SZABO
-
依托单位:
Inhibition of Bacterial and Host-Derived H2S Production for the Therapeutic Enhancement of Anti-Bacterial Host Defense
-
批准号:9245424
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2016
-
负责人:CSABA SZABO
-
依托单位:
Regulation of cellular bioenergetics by hydrogen sulfide
-
批准号:8989546
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2014
-
负责人:CSABA SZABO
-
依托单位:
Poly(ADP-ribose) synthetase inhibition and diabetes
-
批准号:6582906
-
项目类别:
-
资助金额:$19.98万
-
财政年份:2004
-
负责人:CSABA SZABO
-
依托单位:
Mechanisms of cardiovascular dysfunction in diabetes
-
批准号:7149104
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2002
-
负责人:CSABA SZABO
-
依托单位:
Mechanisms of cardiovascular dysfunction in diabetes
-
批准号:6541371
-
项目类别:
-
资助金额:$40.54万
-
财政年份:2002
-
负责人:CSABA SZABO
-
依托单位:
Doxorubicin cardiotoxicity:protection by peroxynitrite
-
批准号:6691686
-
项目类别:
-
资助金额:$17.48万
-
财政年份:2002
-
负责人:CSABA SZABO
-
依托单位:
Doxorubicin cardiotoxicity:protection by peroxynitrite
-
批准号:6548807
-
项目类别:
-
资助金额:$5.89万
-
财政年份:2002
-
负责人:CSABA SZABO
-
依托单位:
Mechanisms of cardiovascular dysfunction in diabetes
-
批准号:6654911
-
项目类别:
-
资助金额:$41.17万
-
财政年份:2002
-
负责人:CSABA SZABO
-
依托单位:
Mechanisms of cardiovascular dysfunction in diabetes
-
批准号:6784056
-
项目类别:
-
资助金额:$41.81万
-
财政年份:2002
-
负责人:CSABA SZABO
-
依托单位:
(ADP-ribose) synthetase inhibitor for multiple sclerosis
-
批准号:6403320
-
项目类别:
-
资助金额:$21.55万
-
财政年份:2001
-
负责人:CSABA SZABO
-
依托单位:
Novel antioxidants for periodontal disease
-
批准号:6582323
-
项目类别:
-
资助金额:$96.19万
-
财政年份:2000
-
负责人:CSABA SZABO
-
依托单位:
PARS INHIBITOR FOR THE THERAPY OF CIRCULATORY SHOCK
-
批准号:6294765
-
项目类别:
-
资助金额:$87.68万
-
财政年份:1999
-
负责人:CSABA SZABO
-
依托单位:
POLY (ADP RIBOSE) SYNTHETASE AND PEROXYNITRITE INDUCED C
-
批准号:6387104
-
项目类别:
-
资助金额:$22.02万
-
财政年份:1999
-
负责人:CSABA SZABO
-
依托单位:
POLY (ADP RIBOSE) SYNTHETASE AND PEROXYNITRITE INDUCED C
-
批准号:6181517
-
项目类别:
-
资助金额:$21.38万
-
财政年份:1999
-
负责人:CSABA SZABO
-
依托单位:
Adenosine-3 agonists for the suppression of arthritis
-
批准号:6442606
-
项目类别:
-
资助金额:$73.0万
-
财政年份:1999
-
负责人:CSABA SZABO
-
依托单位:
POLY (ADP-RIBOSE) SYNTHETASE AND REPERFUSION INJURY
-
批准号:2857941
-
项目类别:
-
资助金额:$20.31万
-
财政年份:1999
-
负责人:CSABA SZABO
-
依托单位:
Peroxynitrate neutralizing agents for stroke therapy
-
批准号:6482163
-
项目类别:
-
资助金额:$72.88万
-
财政年份:1999
-
负责人:CSABA SZABO
-
依托单位:
PARS and peroxynitrite induced cell death
-
批准号:7140967
-
项目类别:
-
资助金额:$32.27万
-
财政年份:1999
-
负责人:CSABA SZABO
-
依托单位:
Peroxynitrate neutralizing agents for stroke therapy
-
批准号:6659048
-
项目类别:
-
资助金额:$95.11万
-
财政年份:1999
-
负责人:CSABA SZABO
-
依托单位:
海外基金